Ignite Creation Date:
2024-05-05 @ 12:06 PM
Last Modification Date:
2024-10-26 @ 9:20 AM
Study NCT ID:
NCT00242073
Status:
COMPLETED
Last Update Posted:
2017-09-21
First Post:
2005-10-18
Brief Title:
The Potential Use of BOLD MRI as a Noninvasive Measure of Tumor Hypoxia in Prostate Cancer
Sponsor:
University Health Network Toronto
Organization:
University Health Network Toronto
Study Overview
Official Title:
The Potential Use of BOLD MRI as a Noninvasive Measure of Tumor Hypoxia in Prostate Cancer
Status:
COMPLETED
Status Verified Date:
2017-09
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Hypoxia low oxygen level is know to be present in many tumors and may strongly influence the success of treatment and the progression of disease in prostate cancer The method used to measure tumor oxygen levels in prostate cancer is to place a needle in the prostate itself through the rectum Blood oxygen level dependent imaging BOLD MRI is a special MRI technique that allows indirect assessment of oxygen levels in blood This technique is non-invasive involving no needles BOLD has not been applied in humans in prostate cancer The purpose of this study is to develop a MRI-BOLD technique that allows us to non-invasively measure changes related to tumor hypoxia in prostate cancer This technique may provide information that will be an independent predictor of patient survival tumor recurrence and likelihood of treatment response in prostate cancer
Detailed Description:
Hypoxia low oxygen level is know to be present in many tumors and may strongly influence the success of treatment and the progression of disease in prostate cancer The method used to measure tumor oxygen levels in prostate cancer is to place a needle in the prostate itself through the rectum Blood oxygen level dependent imaging BOLD MRI is a special MRI technique that allows indirect assessment of oxygen levels in blood This technique is non-invasive involving no needles BOLD has not been applied in humans in prostate cancer The purpose of this study is to develop a MRI-BOLD technique that allows us to non-invasively measure changes related to tumor hypoxia in prostate cancer This technique may provide information that will be an independent predictor of patient survival tumor recurrence and likelihood of treatment response in prostate cancer
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None